Evidence map›Paper›PMID 32562647›Full record

ArticleThe Lancet. Global health2020

Initial findings from a novel population-based child mortality surveillance approach: a descriptive study.

Allan W Taylor, Dianna M Blau, Quique Bassat, Dickens Onyango, Karen L Kotloff, Shams El Arifeen, Inacio Mandomando, Richard Chawana, Vicky L Baillie, Victor Akelo and 23 more

Abstract read
In one paragraph

Article in The Lancet. Global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Genomic analysis ofbioRxiv : the preprint server for biology · 2026
    Article
  15. Article
  16. Connections betweenInfection and immunity · 2026
    Article
  17. Article
  18. Nasopharyngeal Microbiota in South African Infants With Lower Respiratory Tract Infection: A Nested Case-Control Study of the Drakenstein Child Health Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  19. Genomic Characterization ofOpen forum infectious diseases · 2026
    Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Allan W TaylorCenter for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Dianna M BlauCenter for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Quique BassatISGlobal, Hospital Clínic, University of Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain; Pediatrics Department, Pediatric Infectious Diseases Unit, Hospital Sant Joan de Déu, Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Dickens OnyangoKisumu County Department of Health, Kisumu, Kenya.
Karen L KotloffDepartment of Pediatrics, Center for Vaccine Development and Global Health and Division of Infectious Disease and Tropical Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA.
Shams El ArifeenInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Inacio MandomandoCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Richard ChawanaMedical Research Council, Respiratory and Meningeal Pathogens Research Unit, School of Pathology and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Vicky L BaillieMedical Research Council, Respiratory and Meningeal Pathogens Research Unit, School of Pathology and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Victor AkeloCDC Kenya, Kisumu, Kenya.
Milagritos D TapiaDepartment of Pediatrics, Center for Vaccine Development and Global Health and Division of Infectious Disease and Tropical Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA.
Navit T SalzbergEmory Global Health Institute, Emory University, Atlanta, GA, USA.
Adama Mamby KeitaCentre for Vaccine Development, Bamako, Mali.
Timothy MorrisEmory Global Health Institute, Emory University, Atlanta, GA, USA; Public Health Informatics Institute, Task Force for Global Health, Atlanta, GA, USA.
Shailesh NairEmory Global Health Institute, Emory University, Atlanta, GA, USA; Public Health Informatics Institute, Task Force for Global Health, Atlanta, GA, USA.
Nega AssefaCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Anna C SealeLondon School of Hygiene & Tropical Medicine, London, UK.
J Anthony G ScottLondon School of Hygiene & Tropical Medicine, London, UK.
Reinhard KaiserCDC Sierra Leone, Freetown, Sierra Leone.
Amara JambaiMinistry of Health and Sanitation, Freetown, Sierra Leone.
Beth A Tippet BarrCenter for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Emily S GurleyInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh; Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Jaume OrdiISGlobal, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Sherif R ZakiNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Samba O SowCentre for Vaccine Development, Bamako, Mali.
Farzana IslamInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Afruna RahmanInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Scott F DowellBill & Melinda Gates Foundation, Seattle, WA, USA.
Jeffrey P KoplanEmory Global Health Institute, Emory University, Atlanta, GA, USA.
Pratima L RaghunathanCenter for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Shabir A MadhiMedical Research Council, Respiratory and Meningeal Pathogens Research Unit, School of Pathology and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Robert F BreimanEmory Global Health Institute, Emory University, Atlanta, GA, USA. Electronic address: rfbreiman@emory.edu.
CHAMPS Consortium

Funding

Wellcome Trust 205184/Z/16/Z
6 · The paper itself

Abstract

backgroundSub-Saharan Africa and south Asia contributed 81% of 5·9 million under-5 deaths and 77% of 2·6 million stillbirths worldwide in 2015. Vital registration and verbal autopsy data are mainstays for the estimation of leading causes of death, but both are non-specific and focus on a single underlying cause. We aimed to provide granular data on the contributory causes of death in stillborn fetuses and in deceased neonates and children younger than 5 years, to inform child mortality prevention efforts.

methodsThe Child Health and Mortality Prevention Surveillance (CHAMPS) Network was established at sites in seven countries (Baliakandi, Bangladesh; Harar and Kersa, Ethiopia; Siaya and Kisumu, Kenya; Bamako, Mali; Manhiça, Mozambique; Bombali, Sierra Leone; and Soweto, South Africa) to collect standardised, population-based, longitudinal data on under-5 mortality and stillbirths in sub-Saharan Africa and south Asia, to improve the accuracy of determining causes of death. Here, we analysed data obtained in the first 2 years after the implementation of CHAMPS at the first five operational sites, during which surveillance and post-mortem diagnostics, including minimally invasive tissue sampling (MITS), were used. Data were abstracted from all available clinical records of deceased children, and relevant maternal health records were also extracted for stillbirths and neonatal deaths, to incorporate reported pregnancy or delivery complications. Expert panels followed standardised procedures to characterise causal chains leading to death, including underlying, intermediate (comorbid or antecedent causes), and immediate causes of death for stillbirths, neonatal deaths, and child (age 1-59 months) deaths.

findingsBetween Dec 10, 2016, and Dec 31, 2018, MITS procedures were implemented at five sites in Mozambique, South Africa, Kenya, Mali, and Bangladesh. We screened 2385 death notifications for inclusion eligibility, following which 1295 families were approached for consent; consent was provided for MITS by 963 (74%) of 1295 eligible cases approached. At least one cause of death was identified in 912 (98%) of 933 cases (180 stillbirths, 449 neonatal deaths, and 304 child deaths); two or more conditions were identified in the causal chain for 585 (63%) of 933 cases. The most common underlying causes of stillbirth were perinatal asphyxia or hypoxia (130 [72%] of 180 stillbirths) and congenital infection or sepsis (27 [15%]). The most common underlying causes of neonatal death were preterm birth complications (187 [42%] of 449 neonatal deaths), perinatal asphyxia or hypoxia (98 [22%]), and neonatal sepsis (50 [11%]). The most common underlying causes of child deaths were congenital birth defects (39 [13%] of 304 deaths), lower respiratory infection (37 [12%]), and HIV (35 [12%]). In 503 (54%) of 933 cases, at least one contributory pathogen was identified. Cytomegalovirus, Escherichia coli, group B Streptococcus, and other infections contributed to 30 (17%) of 180 stillbirths. Among neonatal deaths with underlying prematurity, 60% were precipitated by other infectious causes. Of the 275 child deaths with infectious causes, the most common contributory pathogens were Klebsiella pneumoniae (86 [31%]), Streptococcus pneumoniae (54 [20%]), HIV (40 [15%]), and cytomegalovirus (34 [12%]), and multiple infections were common. Lower respiratory tract infection contributed to 174 (57%) of 304 child deaths.

interpretationCause of death determination using MITS enabled detailed characterisation of contributing conditions. Global estimates of child mortality aetiologies, which are currently based on a single syndromic cause for each death, will be strengthened by findings from CHAMPS. This approach adds specificity and provides a more complete overview of the chain of events leading to death, highlighting multiple potential interventions to prevent under-5 mortality and stillbirths.

fundingBill & Melinda Gates Foundation.

Indexed as

Child MortalityAfrica South of the SaharaAutopsyCause of DeathChild, PreschoolHumansInfantInfant, NewbornLongitudinal StudiesPopulation SurveillanceSouth Africa

Identifiers

PMID32562647
PMCPMC7303945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.